← Back to Search

Other

LIQUICURE for Fungal Nail Infection (CT001 Trial)

N/A
Waitlist Available
Led By Beth Goldstein, MD
Research Sponsored by Chesson Laboratory Associates, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial tests LIQUICURE, a topical product for people with nail fungus. It penetrates nails better due to its slow drying formula, helping to stop fungal growth. The goal is to clear the infection over several months with minimal side effects.

Eligible Conditions
  • Fungal Nail Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: LIQUICUREExperimental Treatment1 Intervention
Medical Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
LIQUICURE
2008
N/A
~70

Find a Location

Who is running the clinical trial?

Chesson Laboratory Associates, IncLead Sponsor
Beth Goldstein, MDPrincipal InvestigatorCentral Dermatology
~4 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top